Global COPD Drugs Market Forecast to 2023 COPD Market Report | Page 27

Executive Summary
Market
Drivers & Challenges
Trends
• Drivers
Global
COPD
Drugs
market

anticipated to advance at a high CAGR
of
 Once-Daily
is
Rising
Pollution
Level
and
Prevalence.
 Increased Awareness.
due to the rising smoking prevalence,  Increasing Geriatric Population.
geriatric
population,
Combination
Therapy.
 Stem Cell Therapy For COPD.
2.47 % during 2018-2023, mainly
growing
Smoking
Triple
and
• Challenges
increasing pollution level.
Competitive Landscape
 Low Awareness
Glaxo
SmithKline,
AstraZeneca,
Boehringer-Ingelheim,
TEVA
Pharmaceuticals,
Pharmaceuticals, Novartis, Merck, Cipla, Mylan, Vectura, and Sunovion.
(c) AZOTH Analytics
Chiesi
27